Fox News is one of several news outlets carrying an amazing story. Fox’s story is titled “Stem Cell Treatment Credited for Helping Boy, 2, Regain His Sight.” It’s a heart warming story about a 2 year old boy who was born with a rare disease that guaranteed to rob him of his sight. His parents, though, paid $43K to fly to China for a medical procedure using stem cells that they hoped would fix his sight, and that it did. As a father of two boys, of course, I was thrilled to see such a happy outcome, but the pro-lifer in me wanted to know what kind of stem cells were used, so I started digging.
The first link didn’t say, so clicked the link at the end of the story to read the original article written by the Fox affiliate in Orlando. This article, too, lacked the all important detail for which I was searching, so I turned to Google News. A search for the boy’s name (Tre Burgos) turned up four articles, some of which had questionable relevance. The search did, though, turn up an article that brought an end to my short search.
The New Smyrna Beach Observer had an article on the boys plight, but with much more detail, including the object of my quest. Written prior to the Fox News articles above, the NSB Observer reports (emphasis added):
On Feb. 21, of 2008, Elioe [Tre's real name] will travel with his mother and father, to Bieke Biotech Treatment Center in Hangzhou, China and undergo 4-6 umbilical stem cell injections, which consist of 10-15 million cells per injection.
The miracle treatment, then, was not embryonic stem cells, but umbilical, or “adult” stem cells. Now, you can call me paranoid if you want, but why is that the Fox News story doesn’t mention what kind of stem cell was used? Could it be that by trumpeting the success of this stem cell treatment (and omitting the type of stem cells involved), someone hopes to sway the popular opinion with regard to any type of stem cell treatments (namely embryonic), thus removing the political and emotional barriers to emryo-destructive research in the future? Nah, surely not.